Insulin has had a number of 'firsts' in biotechnology. Now it is big business.
"In the 90 years since Leonard Thompson’s astounding recovery, insulin has time and time again found itself in the vanguard of wider scientific advances. And with the diabetic population expected to balloon to over 550 million by 2030, there won’t be any shortage of people reaping the benefits of research into this remarkable protein."
http://www.rsc.org/chemistryworld/2014/11/insulin-podcast
However, "Lack of reasonably priced insulin threatens lives for the poor" (source insulinforall.org)
"In the 90 years since Leonard Thompson’s astounding recovery, insulin has time and time again found itself in the vanguard of wider scientific advances. And with the diabetic population expected to balloon to over 550 million by 2030, there won’t be any shortage of people reaping the benefits of research into this remarkable protein."
http://www.rsc.org/chemistryworld/2014/11/insulin-podcast
However, "Lack of reasonably priced insulin threatens lives for the poor" (source insulinforall.org)
No comments:
Post a Comment